Johannes Jacob Pieter Kastelein New Amsterdam Pharma CO N.V. (NAMS) insider trading activity
Shares Held (Direct Ownership)
34K
n/a
3M change
n/a
12M change
Total Value Held
N/A
JJP
Johannes Jacob Pieter Kastelein
Chief Scientific Officer
Naarden, P7